Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Gerpinnes – page 41

599 clinical trials in Gerpinnes, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Gerpinnes at a glance
599
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

599 trials in Gerpinnes

Open in trial search

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study of Nacystelyn for Patients with Obstructive Sleep Apnea

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nacystelyn
  • Sponsor:Laboratoires S.M.B.

Study of Durvalumab in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Study comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Selpercatinib
  • Sponsor:Eli Lilly & Co.

Cervix carcinoma

Not recruiting

Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Mantle cell lymphoma

Not recruiting

Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:BeOne Medicines AG

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Calcium Folinate
  • Sponsor:Merck Sharp & Dohme LLC

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Association International Extranodal Lymphoma Study Group (IELSG)

Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atigotatug
  • Sponsor:Bristol Myers Squibb International Corporation

Psoriasis

Not recruiting

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Brodalumab
  • Sponsor:Leo Pharma A/S

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Gerpinnes

What the registry says about research in the country

01 Dermatology Research

Innovative clinical studies focusing on prurigo nodularis and hidradenitis suppurativa, evaluating novel therapeutic approaches for chronic skin conditions.

  • Itch and skin lesion management
  • Inflammatory skin disorders
  • Treatment-resistant conditions

Research aims to provide relief for patients with moderate to severe symptoms who haven't responded to conventional treatments.

02 Oncology Studies

Comprehensive research targeting various forms of gynecological cancers, including innovative treatments for ovarian, fallopian tube, and endometrial cancers.

  • Recurrent ovarian cancer therapy
  • Combined immunotherapy approaches
  • MUC16+ cancer treatments

Investigation of novel combination therapies to improve outcomes in recurrent cancers.

03 Emergency Medicine

Ground-breaking research in severe burn treatment and critical care, examining high-dose vitamin C therapy for life-threatening thermal injuries.

  • Organ dysfunction prevention
  • Burn trauma management
  • Critical care interventions

Studies focus on reducing mortality and improving outcomes in severely burned patients through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.